A Recognized Leader in Cell and Gene Therapy (CGT)
The Cincinnati Children’s Applied Gene and Cell Therapy Center is a clinical-stage research, development, and manufacturing hub advancing future CGT treatments for patients with unmet needs.
Originating from the Translational Core Laboratory established in 2003, the center has evolved into a nationally recognized leader in CGT, CGT CDMO services with a proven track record of service excellence.
With a $60 million investment in a cutting-edge facility, the center is expanding its capacity to deliver transformative therapies for cancer, autoimmune diseases, infectious diseases, blood diseases, and other genetic disorders. This growth builds on more than 15 years of CGT expertise and reflects Cincinnati Children’s commitment to solving unmet medical needs through translational science.
